Winter 2011

Winter 2011 issue:

Aortic Valve Replacement 

Inoperable patients with severe symptomatic aortic stenosis have survival rates as low as 50 percent within two years of symptom onset. A team of Washington University cardiac surgeons and interventional cardiologists at Barnes-Jewish Hospital has developed unique expertise in a new technology— percutaneous aortic valve replacement— that makes AVR an option for these highrisk patients.

Also in this issue:

• Gene Identified for Spread of Deadly Melanoma 
• Siteman Receives Renewal of Comprehensive Cancer Center Status 
• New Transplant Option Offers Hope for Kidney Patients 
• Photodynamic Therapy for Localized Prostate Cancer 
• Stroke Imaging 
• $30 Million Project Will Map the Brains Wiring 
• Eliminating Cancer Disparities Focus of Grant to Siteman 
• Developments in Asthma Treatment 
• Bariatric Program Helps Curb Adolescent Obesity 
• Excellence in Spine Surgery